concept

DIMETHYL FUMARATE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about DIMETHYL FUMARATE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

136Connections

0Hypotheses

6Analyses

50Outgoing

18Incoming

0Experiments

7Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	DIMETHYL FUMARATE
Key Genes/Proteins	APP, CGAS
Related Diseases	ACETYLCHOLINE, ALZHEIMER, ALZHEIMER'S DISEASE, APOPTOSIS, AUTOPHAGY
Related Pathways	CGAS-STING PATHWAY

Pathway Diagram

graph TD
    DIMETHYL_FUMARATE["DIMETHYL FUMARATE"]
    DIMETHYL_FUMARATE -->|"activates"| NFE2L2["NFE2L2"]
    DIMETHYL_FUMARATE -->|"treats"| Cognitive_Impairment["Cognitive Impairment"]
    DIMETHYL_FUMARATE -->|"treats"| Cognitive_Dysfunction["Cognitive Dysfunction"]
    DIMETHYL_FUMARATE -->|"modulates"| ASTROCYTES["ASTROCYTES"]
    DIMETHYL_FUMARATE -->|"inhibits"| STAT3["STAT3"]
    DIMETHYL_FUMARATE -->|"treats"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
    DIMETHYL_FUMARATE -->|"activates"| NRF2_PATHWAY["NRF2 PATHWAY"]
    DIMETHYL_FUMARATE -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
    ASTROCYTES -->|"activates"| DIMETHYL_FUMARATE
    APP["APP"] -->|"activates"| DIMETHYL_FUMARATE

Outgoing (118)

Target	Relation	Type	Str
NRF2 activation	activates	pathway	0.90
NFE2L2	activates	gene	0.90
ferroptosis	prevents	process	0.90
lymphopenia	causes	phenotype	0.90
NRF2	activates	protein	0.90
Cognitive Impairment	treats	phenotype	0.88
Cognitive Dysfunction	treats	phenotype	0.88
STAT3	inhibits	gene	0.85
ASTROCYTES	modulates	cell_type	0.85
ALZHEIMER'S DISEASE	treats	disease	0.82
Ferroptosis	protects_against	mechanism	0.70
Alzheimer disease	therapeutic_target_for	disease	0.70
Alzheimer's disease	therapeutic_target_for	disease	0.70
neurodegeneration	therapeutic_target_for	disease	0.70
LC3	activates	gene	0.70
PINK1	activates	gene	0.70
REST pathway restoration	therapeutic_target_for	process	0.70
NECROPTOSIS	inhibits	phenotype	0.65
MULTIPLE SCLEROSIS	treats	disease	0.65
AUTOPHAGY	treats	phenotype	0.65
AUTOPHAGY	regulates	phenotype	0.65
OXIDATIVE STRESS	activates	phenotype	0.65
MULTIPLE SCLEROSIS	interacts_with	disease	0.65
INFLAMMATION	treats	phenotype	0.65
NRF2	regulates	gene	0.65
NRF2	associated_with	gene	0.65
CGAS-STING PATHWAY	activates	pathway	0.65
MULTIPLE SCLEROSIS	activates	disease	0.65
NRF2 PATHWAY	activates	pathway	0.65
MAP1LC3	activates	gene	0.60
GFP	activates	gene	0.60
NLR	activates	gene	0.60
GFP	regulates	gene	0.60
NLR	regulates	gene	0.60
MAP1LC3	regulates	gene	0.60
NDP52	activates	gene	0.60
OPTN	activates	gene	0.60
CASP3	activates	gene	0.60
mitochondrial dynamics	modulates	pathway	0.60
HTT	regulates	gene	0.60
LC3	regulates	gene	0.60
NBR1	regulates	gene	0.60
BCL2	regulates	gene	0.60
PRKN	regulates	gene	0.60
HTT	activates	gene	0.60
GAPDH	regulates	gene	0.60
PTEN	regulates	gene	0.60
PINK1	regulates	gene	0.60
NDP52	regulates	gene	0.60
OPTN	regulates	gene	0.60

Incoming (18)

Source	Relation	Type	Str
34477330	suppresses	paper	0.90
34477330	was safe and well-tolerated in	paper	0.90
34477330	showed lack of	paper	0.90
34477330	enhances	paper	0.90
34477330	did not significantly improve	paper	0.90
34477330	was	paper	0.90
34477330	showed	paper	0.90
34477330	enhances and suppresses	paper	0.60
34477330	was associated with reduced	paper	0.60
CGAS-STING PATHWAY	associated_with	pathway	0.50
MULTIPLE SCLEROSIS	associated_with	disease	0.45
ALZHEIMER	associated_with	disease	0.45
APP	associated_with	gene	0.45
ASTROCYTES	associated_with	cell_type	0.45
PARKINSON'S DISEASE	associated_with	disease	0.45
APP	activates	gene	0.35
ASTROCYTES	activates	cell_type	0.35
ALZHEIMER'S DISEASE	associated_with	disease	0.35

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (6)

Scientific analyses that reference this entity

Ferroptosis in ALS and motor neuron disease: GPX4, lipid peroxidation, and iron

neurodegeneration | 2026-04-16 | 7 hypotheses Top: 0.680

Gene Regulatory Network Inference in Alzheimer's Disease

neurodegeneration | 2026-04-16 | 1 hypotheses Top: 0.661

What determines the GPX4/ACSL4 balance that switches microglia from protective t

immunology | 2026-04-15 | 0 hypotheses

How do ALS-associated OPTN mutations mechanistically disrupt Rab8a binding and c

neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.521

Do PINK1/PARKIN pathway enhancements rescue excitatory neuron vulnerability or e

neurodegeneration | 2026-04-11 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (7)

Multi-agent debates referencing this entity

The core debate question remains unresolved - whether intrinsic tau conformation

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

Which transcription factors drive the gene regulatory networks that distinguish

closed · Rounds: 4 · Score: 0.70 · 2026-04-21

The debate revealed a critical gap: while PINK1/PARKIN deficiency correlates wit

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

Ferroptosis in ALS and motor neuron disease: GPX4, lipid peroxidation, and iron

closed · Rounds: 5 · Score: 0.59 · 2026-04-16

Is REST the master regulator of neuronal vulnerability in AD, or is it one of se

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

While ACSL4-driven ferroptosis was strongly supported, the molecular triggers th

closed · Rounds: 4 · Score: 0.80 · 2026-04-16

The authors evaluate several ALS-associated mutations in OPTN's leucine-zipper d

closed · Rounds: 4 · Score: 0.95 · 2026-04-16

Related Research

Hypotheses and analyses mentioning DIMETHYL FUMARATE in their description or question text

No additional research found

DIMETHYL FUMARATE

Understanding Entity Pages

Pathway Diagram

Outgoing (118)

Incoming (18)

Targeting Hypotheses (0)

Mentioning Analyses (6)

Ferroptosis in ALS and motor neuron disease: GPX4, lipid peroxidation, and iron

Gene Regulatory Network Inference in Alzheimer's Disease

What determines the GPX4/ACSL4 balance that switches microglia from protective t

How do ALS-associated OPTN mutations mechanistically disrupt Rab8a binding and c

Do PINK1/PARKIN pathway enhancements rescue excitatory neuron vulnerability or e

Do tau strains or regional cellular environments primarily drive PSP vs CBD path

Experiments (0)

Related Papers (0)

Debates (7)

The core debate question remains unresolved - whether intrinsic tau conformation

Which transcription factors drive the gene regulatory networks that distinguish

The debate revealed a critical gap: while PINK1/PARKIN deficiency correlates wit

Ferroptosis in ALS and motor neuron disease: GPX4, lipid peroxidation, and iron

Is REST the master regulator of neuronal vulnerability in AD, or is it one of se

While ACSL4-driven ferroptosis was strongly supported, the molecular triggers th

The authors evaluate several ALS-associated mutations in OPTN's leucine-zipper d

Related Research